ACG ACPL becomes first Asian company to receive EXCiPACT certification

ACG Worldwide is pleased to announce that ACG Associated Capsules Pvt Ltd (ACG ACPL) has received EXCiPACT certification for its plant at Dahanu (Maharashtra, India).

ACG ACPL is the first empty hard capsule manufacturing company in Asia to receive EXCiPACT certification. The certificate provides independent validation that ACG ACPL maintains excipient good manufacturing practices (GMPs) and complies with current EU and US FDA regulations.

'We give paramount importance to maintaining the highest quality while complying with current regulations at ACG ACPL. This has been the key driver to help us achieve market leadership and create long-term relationships with our global customers,' said Quateel Ahmed, CMO, ACG Worldwide.

'ACG ACPL endeavours to maintain the company’s quality and compliance policies that surpass current regulatory norms. We are delighted to become the first Asian company to receive the prominent EXCiPACT certification,' he added.

Large pharmaceutical companies use thousands of excipients when manufacturing formulations. However, it is practically impossible to conduct all the necessary audits themselves.

To resolve this issue, EXCiPACT was created by IPEC Europe, IPEC Americas, FECC, EFCG and PQG as a rigorous, independent, third-party audit system to respond to regulatory requirements and reduce the audit burden of pharmaceutical companies as well as audit authorities.

EXCiPACT thus helps to ensure patient safety through supplier quality, while minimising the overall supply chain costs. The user — that is, the pharmaceutical industry — can take this standardised audit report as a valid reference for their regulatory compliance without having to do the audit by themselves or by appointing another agency.